|
Conflict of interest statement
The author(s) declared no potential conflicts of
interest with respect to the research, authorship,
and/or publication of this article.
ORCID iD
Salvatore Santo Signorelli
https://orcid.org
/0000-0001-9264-0061
References
1. Ankle Brachial Index Collaboration, Fowkes
FG, Murray GD, et al. Ankle brachial index
combined with Framingham risk score to
predict cardiovascular events and mortality: a
meta-analysis. JAMA 2008; 300: 197–208.
2. Steg PG, Bhatt DL, Wilson PW, et al. One-year
cardiovascular event rates in outpatients with
atherothrombosis. JAMA 2007; 297: 1197–1206.
3. Bhatt DL, Eagle KA, Ohman EM, et al.
Comparative determinants of 4-year
cardiovascular event rates in stable outpatients
at risk of or with atherothrombosis. JAMA
2010; 304: 1350–1357.
4. Sampson UK, Fowkes FG, McDermott MM,
et al. Global and regional burden of death and
disability from peripheral artery disease: 21
world regions, 1990 to 2010. Global Heart 2014;
9: 145–158.e21.
5. Fowkes FG, Housley E, Cawood EH,
et al. Edinburgh artery study: prevalence of
asymptomatic and symptomatic peripheral
arterial disease in the general population. Int J
Epidemiol 1991; 20: 384–392.
6. Allison MA, Ho E, Denenberg JO, et al. Ethnic-
specific prevalence of peripheral arterial disease
in the United States. Am J Prev Med 2007; 32:
328–333.
7. Hirsch AT, Criqui MH, Treat-Jacobson D,
et al. Peripheral arterial disease detection,
awareness, and treatment in primary care.
JAMA 2001; 286: 1317–1324.
8. Malyar N, Fürstenberg T, Wellmann J, et al.
Recent trends in morbidity and in-hospital
outcomes of in-patients with peripheral arterial
disease: a nationwide population-based analysis.
Eur Heart J 2013; 34: 2706–2714.
9. Kröger K, Stang A, Kondratieva J, et al.
Prevalence of peripheral arterial disease -
results of the Heinz Nixdorf recall study. Eur J
Epidemiol 2006; 21: 279–285.
10. Bowlin SJ, Medalie JH, Flocke SA, et al.
Epidemiology of intermittent claudication in
middle-aged men. Am J Epidemiol 1994; 140:
418–430.
11. Hiatt WR, Hoag S and Hamman RF. Effect
of diagnostic criteria on the prevalence of
peripheral arterial disease. The San Luis valley
diabetes study. Circulation 1995; 91: 1472–
1479.
12. Murabito JM, Evans JC, Nieto K, et al.
Prevalence and clinical correlates of peripheral
arterial disease in the Framingham offspring
study. Am Heart J 2002; 143: 961–965.
13. Selvin E and Erlinger TP. Prevalence of and
risk factors for peripheral arterial disease in the
United States: results from the National health
and nutrition examination survey, 1999–2000.
Circulation 2004; 110: 738–743.
14. Sigvant B, Wiberg-Hedman K, Bergqvist D,
et al. A population- based study of peripheral
arterial disease prevalence with special focus on
critical limb ischemia and sex differences. J Vasc
Surg 2007; 45: 1185–1191.
15. Mostaza JM, Manzano L, Suárez C, et al.
Prevalence of asymptomatic peripheral artery
disease detected by the ankle-brachial index in
patients with cardiovascular disease. MERITO
II study. Med Clin (Barc) 2008; 131: 561–565.
16. Ramos R, Quesada M, Solanas P, et al.
Prevalence of symptomatic and asymptomatic
peripheral arterial disease and the value of the
ankle-brachial index to stratify cardiovascular
SS Signorelli, L Vanella et al.
journals.sagepub.com/home/taj 11
risk. Eur J Vasc Endovasc Surg 2009; 38:
305–311.
17. Alzamora MT, Forés R, Baena-Díez JM , et al.
The peripheral arterial disease study (PERART/
ARTPER): prevalence and risk factors in the
general population. BMC Public Health 2010;
10: 38.
18. Signorelli SS, Anzaldi M, Fiore V, et al. Study
on unrecognized peripheral arterial disease
(PAD) by ankle/brachial index and arterial
comorbidity in Catania, Sicily, Italy. Angiology
2010; 61: 524–529.
19. Fowkes FG, Rudan D, Rudan I, et al.
Comparison of global estimates of prevalence
and risk factors for peripheral artery disease
in 2000 and 2010: a systematic review and
analysis. Lancet 2013; 382: 1329–1340.
20. Sigvant B, Hasvold P, Kragsterman B, et al.
Cardiovascular outcomes in patients with
peripheral arterial disease as an initial or
subsequent manifestation of atherosclerotic
disease: results from a Swedish nationwide
study. J Vasc Surg 2017; 66: 507–514.
21. Signorelli S, Anzaldi M, Fiore V, et al. Patients
with unrecognized peripheral arterial disease
(PAD) assessed by ankle-brachial index (ABI)
present a defined profile of proinflammatory
markers compared to healthy subjects. Cytokine
2012; 59: 294–298.
22. Fontaine R, Kim M and Kieny R. Surgical
treatment of peripheral circulation disorders
[article in German]. Helv Chir Acta 1954; 21:
499–533.
23. Rutherford RB, Baker JD, Ernst C, et al.
Recommended standards for reports dealing
with lower extremity ischemia: revised version.
Do'stlaringiz bilan baham: | 
